These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20637129)

  • 21. Southern Tunisia: A still high endemicity area for hepatitis A.
    Neffatti H; Lebraud P; Hottelet C; Gharbi J; Challouf T; Roque-Afonso AM
    PLoS One; 2017; 12(4):e0175887. PubMed ID: 28426700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical performance of newly developed rapid point-of-care test for the simultaneous detection of hepatitis A, B, and C viruses in serum samples.
    Kweon OJ; Lim YK; Kim HR; Kim TH; Lee MK
    J Med Virol; 2019 Jun; 91(6):1056-1062. PubMed ID: 30668895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypes of hepatitis a virus in Turkey: first report and clinical profile of children infected with sub-genotypes IA and IIIA.
    Yilmaz H; Karakullukcu A; Turan N; Cizmecigil UY; Yilmaz A; Ozkul AA; Aydin O; Gunduz A; Mete M; Zeyrek FY; Kirazoglu TT; Richt JA; Kocazeybek B
    BMC Infect Dis; 2017 Aug; 17(1):561. PubMed ID: 28800730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand.
    Poovorawan Y; Theamboonlers A; Chongsrisawat V; Jantaradsamee P; Chutsirimongkol S; Tangkijvanich P
    J Clin Virol; 2005 Jan; 32(1):24-8. PubMed ID: 15572002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The important role of early diagnosis and preventive management during a large-scale outbreak of hepatitis A in Thailand.
    Poovorawan K; Chattakul P; Chattakul S; Thongmee T; Theamboonlers A; Komolmit P; Poovorawan Y
    Pathog Glob Health; 2013 Oct; 107(7):367-72. PubMed ID: 24392680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors for predicting positive results for anti-HAV IgM retesting among initially seronegative patients.
    Shin HP; Lee JI; Jung SW; Cha JM; Joo KR; Kang SY
    Dig Dis Sci; 2010 Dec; 55(12):3537-40. PubMed ID: 20108041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunoenzymatic assay for the diagnosis of hepatitis A utilising immunoglobulin Y.
    Silva Ados S; Vasconcelos GA; Kappel LA; Pinto MA; Paula VS
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):960-3. PubMed ID: 23147158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis A in Iceland].
    Kristinsdóttir H; Löve A; Bjornsson ES
    Laeknabladid; 2018 Mars; 104(3):127-131. PubMed ID: 29493530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory.
    Cho SE; Kim Y
    J Epidemiol; 2013; 23(4):270-4. PubMed ID: 23629647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of dried serum spots for serological and molecular detection of hepatitis a virus.
    Desbois D; Roque-Afonso AM; Lebraud P; Dussaix E
    J Clin Microbiol; 2009 May; 47(5):1536-42. PubMed ID: 19321728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA testing for the diagnosis of acute hepatitis A during the 2017 outbreak in France.
    Tram J; Le Baccon-Sollier P; Bolloré K; Ducos J; Mondain AM; Pastor P; Pageaux GP; Makinson A; de Perre PV; Tuaillon E
    J Viral Hepat; 2020 May; 27(5):540-543. PubMed ID: 31895489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis A immunity in the District of Aveiro (Portugal): an eleven-year surveillance study (2002-2012).
    Pereira S; Linhares I; Neves AF; Almeida A
    Viruses; 2014 Mar; 6(3):1336-45. PubMed ID: 24638206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant VP1 protein as a potential marker for the diagnosis of acute hepatitis A virus infection.
    da Silva Junior HC; da Silva ED; Lewis-Ximenez de Souza Rodrigues LL; Medeiros MA
    J Virol Methods; 2017 Jul; 245():1-4. PubMed ID: 28284976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus.
    Arcangeletti MC; Dussaix E; Ferraglia F; Roque-Afonso AM; Graube A; Chezzi C
    Clin Vaccine Immunol; 2011 Aug; 18(8):1391-4. PubMed ID: 21653739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A waterborne outbreak involving hepatitis A virus genotype IA at a residential facility in the Republic of Korea in 2015.
    Shin E; Kim JS; Oh KH; Oh SS; Kwon M; Kim S; Park J; Kwak HS; Chung GT; Kim CJ; Kim J
    J Clin Virol; 2017 Sep; 94():63-66. PubMed ID: 28759774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis A virus subgenotypes dissemination during a community outbreak in a surrounding region of Rio de Janeiro.
    Santos DR; Villar LM; Paula VS; Lima GS; Gaspar AM
    Mem Inst Oswaldo Cruz; 2008 May; 103(3):254-8. PubMed ID: 18592098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune hepatitis induced by the prolonged hepatitis A virus infection.
    Tabak F; Ozdemir F; Tabak O; Erer B; Tahan V; Ozaras R
    Ann Hepatol; 2008; 7(2):177-9. PubMed ID: 18626439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Persistence of IgM anti-HAV in prolonged form of HAV-infection].
    Dautović-Krkić S
    Med Arh; 2005; 59(2):91-3. PubMed ID: 15875469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.